Relmada Therapeutics, Inc. · NASDAQ:RLMD

Squadron Capital Management LLC reported a 9.90% stake in Relmada Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 17, 2026

Squadron Capital Management LLC reported a 9.90% stake in Relmada Therapeutics, Inc., 7,395,510 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).

Stake
9.90%
Shares
7,395,510
Intent
Passive
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
Squadron Master Fund LP9.90%7,395,510
Squadron Capital Management LLC9.90%7,395,510
William Blank9.90%7,395,510
Matthew Sesterhenn9.90%7,395,510

Source

View original at SEC

Related